Related Experiment Videos
Percutaneous biopsy in lung cancer
François Laurent1, Michel Montaudon, Valérie Latrabe
1Unité d'Imagerie Thoracique et Cardiovasculaire, Hôpital du Haut-Lévêque, Centre Hospitalier Universitaire de Bordeaux, Avenue de Magellan, Pessac 33604, France. francois.laurent@chu-bordeaux.fr
European Journal of Radiology
|December 25, 2002
Summary
Percutaneous lung biopsy is a valuable diagnostic tool for lung cancer when benefits outweigh risks like pneumothorax. Core biopsies improve diagnostic accuracy for benign conditions and lymphoma.
Area of Science:
- Pulmonology
- Oncology
- Radiology
Background:
- Percutaneous lung biopsy is crucial for diagnosing lung cancer.
- Understanding its indications, contraindications, and complications is vital for patient management.
Purpose of the Study:
- To review the current indications, contraindications, technical aspects, complications, and diagnostic yield of percutaneous lung biopsy for lung cancer.
- To provide guidance on optimizing the procedure for improved patient outcomes.
Main Methods:
- Review of current literature on percutaneous lung biopsy techniques and outcomes.
- Analysis of factors influencing diagnostic yield and complication rates.
Main Results:
- Percutaneous lung biopsy is indicated when therapeutic strategy can be significantly influenced and benefits outweigh risks (pneumothorax, hemorrhage).
- Larger needle size (>18 gauge) is a major risk factor for bleeding; numerous factors favor pneumothorax.
- Core biopsies are more efficient for diagnosing benignity and lymphoma compared to aspiration needles, with similar malignancy yields.
Conclusions:
- Percutaneous lung biopsy is a safe and effective diagnostic procedure for lung cancer when indications are carefully considered.
- Technical advancements in guidance, needle design, and pathology can improve diagnostic yield and reduce complications.